Stem cell markers: Insights from membrane proteomics?

Proteomics

Volumn 8, Issue 23-24, 2008, Pages 4946-4957

  Ahn, Sung Min ^a,b   Goode, Robert J A ^a   Simpson, Richard J ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Gachon University College of Medicine   (South Korea)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cancer stem cells; Cell surface; Membrane; Stem cells

Indexed keywords

CELL MARKER; MEMBRANE PROTEIN;

ANTIBODY AFFINITY; BIOTINYLATION; CANCER STEM CELL; CELL DIFFERENTIATION; CELL MEMBRANE; CELL POPULATION; CELL PROLIFERATION; CYTOLOGY; DENSITY GRADIENT CENTRIFUGATION; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROGENY; PROTEOMICS; REVIEW; STEM CELL;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL MEMBRANE; HUMANS; MEMBRANE PROTEINS; PROTEOMICS; STEM CELLS;

EID: 57649146492     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800312     Document Type: Review

References (122)

1. Eckfeldt, C. E., Mendenhall, E. M., Verfaillie, C. M., The molecular repertoire of the 'almighty' stem cell. Nat. Rev. Mol. Cell Biol. 2005, 6, 726-737.
2. Shamblott, M. J., Axelman, J., Wang, S., Bugg, E. M. et al., Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 1998, 95, 13726-13731.
3. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A. et al., Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
4. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M. et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
5. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J. et al., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
6. Sell, S., Stem Cells Handbook, Humana Press, Totowa, N. J. 2004.
7. McNeish, J., Embryonic stem cells in drug discovery. Nat. Rev. Drug Discov. 2004, 3, 70-80.
8. Sakurada, K., McDonald, F. M., Shimada, F., Regenerative medicine and stem cell based drug discovery. Angew. Chem. Int. Ed. Engl. 2008, 47, 5718-5738.
9. Rolletschek, A., Blyszczuk, P., Wobus, A. M., Embryonic stem cell-derived cardiac, neuronal, and pancreatic cells as model systems to study toxicological effects. Toxicol. Lett. 2004, 149, 361-369.
10. Bremer, S., Hartung, T., The use of embryonic stem cells for regulatory developmental toxicity testing in vitro-the current status of test development. Curr. pharm. des. 2004, 10, 2733-2747.
11. Li, H., Radford, J. C., Ragusa, M. J., Shea, K. L. et al., Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc. Natl. Acad. Sci. USA 2008, 105, 9397-9402.
12. Lindvall, O., Kokaia, Z., Stem cells for the treatment of neurological disorders. Nature 2006, 441, 1094-1096.
13. Bjorklund, A., Lindvall, O., Parkinson disease gene therapy moves toward the clinic. Nat. Med. 2000, 6, 1207-1208.
14. Kordower, J. H., Freeman, T. B., Snow, B. J., Vingerhoets, F. J. et al., Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 1995, 332, 1118-1124.
15. Olanow, C. W., Kordower, J. H., Freeman, T. B., Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 1996, 19, 102-109.
16. Yip, S., Aboody, K. S., Burns, M., Imitola, J., in: Markert, J. M., DeVita, V. T., Hellman, S., Rosenberg, S. A. (Eds.), Glioblastoma Multiforme, Jones and Bartlett Publishers, Sudbury 2005.
17. Kim, S. U., Park, I. H., Kim, T. H., Kim, K. S. et al., Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology 2006, 26, 129-140.
18. Aiba, K., Sharov, A. A., Carter, M. G., Foroni, C. et al., Defining a developmental path to neural fate by global expression profiling of mouse embryonic stem cells and adult neural stem/progenitor cells. Stem Cells 2006, 24, 889-895.
19. Laflamme, M. A., Murry, C. E., Regenerating the heart. Nat. Biotechnol. 2005, 23, 845-856.
20. Pardal, R., Clarke, M. F., Morrison, S. J., Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 2003, 3, 895-902.
21. Sanai, N., Alvarez-Buylla, A., Berger, M. S., Neural stem cells and the origin of gliomas. N. Engl. J. Med. 2005, 353, 811-822.
22. Reya, T., Morrison, S. J., Clarke, M. F., Weissman, I. L., Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105-111.
23. Sell, S., Cancer stem cells and differentiation therapy. Tumour Biol. 2006, 27, 59-70.
24. Sell, S., Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol. Hematol. 2004, 51, 1-28.
25. Perez-Iratxeta, C., Palidwor, G., Porter, C. J., Sanche, N. A. et al., Study of stem cell function using microarray experiments. FEBS Lett. 2005, 579, 1795-1801.
26. Brandenberger, R., Khrebtukova, I., Thies, R. S., Miura, T. et al., MPSS profiling of human embryonic stem cells. BMC dev. biol. 2004, 4, 10.
27. Lunyak, V. V., Rosenfeld, M. G., Epigenetic regulation of stem cell fate. Hum. Mol. Genet. 2008, 17, R28-R36.
28. Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E. et al., Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122, 947-956.
29. Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M. et al., Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008, 134, 521-533.
30. Graumann, J., Hubner, N. C., Kim, J. B., Ko, K. et al., Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5111 proteins. Mol. Cell. Proteomics 2008, 7, 672-683.
31. Simpson, R. J., Purifying proteins for proteomics: A laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. 2004.
32. Davidson, E. H., The regulatory genome: Gene regulatory networks in development and evolution, Elsevier/Academic Press, Oxford Boston 2006.
33. Consortium, I. H. G. S., Finishing the euchromatic sequence of the human genome. Nature 2004, 431, 931-945.
34. Wenick, A. S., Hobert, O., Genomic cis-regulatory architecture and trans-acting regulators of a single interneuron-specific gene battery in C. elegans. Dev. Cell 2004, 6, 757-770.
35. Cheng, L. C., Tavazoie, M., Doetsch, F., Stem cells: From epigenetics to microRNAs. Neuron 2005, 46, 363-367.
36. Reik, W., Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447, 425-432.
37. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells frommouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
38. Feldman, N., Gerson, A., Fang, J., Li, E. et al., G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8, 188-194.
39. Bartel, D. P., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
40. Shalgi, R., Lieber, D., Oren, M., Pilpel, Y., Global and Local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput. Biol. 2007, 3, e131.
41. Elliott, R. L., Blobe, G. C., Role of transforming growth factor Beta in human cancer. J. Clin. Oncol. 2005, 23, 2078-2093.
42. O'Shea, J. J., Gadina, M., Schreiber, R. D., Cytokine signaling in 2002: New surprises in the Jak/Stat pathway. Cell 2002, 109, S121-S131.
43. Krijgsveld, J., Whetton, A. D., Lee, B., Lemischka, I. et al., Proteome biology of stem cells: A new joint HUPO and ISSCR initiative. Mol. Cell. Proteomics 2008, 7, 204-205.
44. Nomura, H., Imazeki, I., Oheda, M., Kubota, N. et al., Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J. 1986, 5, 871-876.
45. Zola, H., Swart, B., Nicholson, I., Aasted, B. et al., CD molecules 2005: Human cell differentiation molecules. Blood 2005, 106, 3123-3126.
46. Metcalf, D., The Florey Lecture, The colony-stimulating factors: Discovery to clinical use. Philos. Trans. R. Soc. Lond. 1991, 333, 147-173.
47. Ivanova, N. B., Dimos, J. T., Schaniel, C., Hackney, J. A. et al., Response to comments on " 'Stemness': Transcriptional profiling of embryonic and adult stem cells" and "A stem cell molecular signature". Science 2003, 302, 393d.
48. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A. et al., Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer cell 2006, 9, 391-403.
49. Suslov, O. N., Kukekov, V. G., Ignatova, T. N., Steindler, D. A., Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres. Proc. Natl. Acad. Sci. USA 2002, 99, 14506-14511.
50. Van Hoof, D., Braam, S. R., Dormeyers, W., Ward-van Oostwaard, D. et al., Feeder-free Monolayer cultures of human embryonic stem cells express an epithelial plasma membrane protein profile. Stem Cells 2008, doi:10.1634/stemcells.2008-0365.
51. Zhong, J. F., Chen, Y., Marcus, J. S., Scherer, A. et al., A microfluidic processor for gene expression profiling of single human embryonic stem cells. Lab chip 2008, 8, 68-74.
52. Alberts, B., Molecular Biology of the Cell, Garland Science, New York 2002.
53. Wallin, E., von Heijne, G., Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci. 1998, 7, 1029-1038.
54. Hopkins, A. L., Groom, C. R., The druggable genome. Nat. Rev. Drug Discov. 2002, 1, 727-730.
55. Bernard, A., Boumsell, L., Human leukocyte differentiation antigens. Presse Med. 1984, 13, 2311-2316.
56. Zola, H., Swart, B. W., Human leucocyte differentiation antigens. Trends immunol. 2003, 24, 353-354.
57. Uhlen, M., Ponten, F., Antibody-based proteomics for human tissue profiling. Mol. Cell. Proteomics 2005, 4, 384-393.
58. Agaton, C., Galli, J., Hoiden Guthenberg, I., Janzon, L. et al., Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol. Cell. Proteomics 2003, 2, 405-414.
59. Uhlen, M., Bjorling, E., Agaton, C., Szigyarto, C. A. et al., A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell. Proteomics 2005, 4, 1920-1932.
60. Woolfson, A., Ellmark, P., Chrisp, J. S. M. A. S., Christopherson, R. I., The application of CD antigen proteomics to pharmacogenomics. Pharmacogenomics 2006, 7, 759-771.
61. Hall, D. A., Ptacek, J., Snyder, M., Protein microarray technology. Mech. Ageing Dev. 2007, 128, 161-167.
62. Bentley, G. A., Boulot, G., Chitarra, V., Cross-reactivity in antibody-antigen interactions. Res. Immunol. 1994, 145, 45-48.
63. Edman, P., Phenylthiohydantoins in protein analysis. Ann. N. Y. Acad. Sci. 1960, 88, 602-610.
64. Hunt, D. F., Yates, J. R. 3rd, Shabanowitz, J., Winston, S., Hauer, C. R., Protein sequencing by tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 1986, 83, 6233-6237.
65. Siuti, N., Kelleher, N. L., Decoding protein modifications using top-down mass spectrometry. Nat. Methods 2007, 4, 817-821.
66. Wu, C. C., Yates, J. R. 3rd, The application of mass spectrometry to membrane proteomics. Nat. Biotechnol. 2003, 21, 262-267.
67. Temporini, C., Calleri, E., Massolini, G., Caccialanza, G., Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins. Mass Spectrom. Rev. 2008, 27, 207-236.
68. Witze, E. S., Old, W. M., Resing, K. A., Ahn, N. G., Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 2007, 4, 798-806.
69. Reinders, J., Sickmann, A., Modificomics: Post-translational modifications beyond protein phosphorylation and glycosylation. Biomol. Eng. 2007, 24, 169-177.
70. Nuhse, T. S., Stensballe, A., Jensen, O. N., Peck, S. C., Large-scale analysis of in vivo phosphorylated membrane proteins by immobilized metal ion affinity chromatography and mass spectrometry. Mol. Cell. Proteomics 2003, 2, 1234-1243.
71. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
72. Mikesh, L. M., Ueberheide, B., Chi, A., Coon, J. J. et al., The utility of ETD mass spectrometry in proteomic analysis. Biochim. Biophys. Acta 2006, 1764, 1811-1822.
73. Shin, B. K., Wang, H., Yim, A. M., Le Naour, F. et al., Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 2003, 278, 7607-7616.
74. Peirce, M. J., Wait, R., Begum, S., Saklatvala, J., Cope, A. P., Expression profiling of lymphocyte plasma membrane proteins. Mol. Cell. Proteomics 2004, 3, 56-65.
75. Nunomura, K., Nagano, K., Itagaki, C., Taoka, M. et al., Cell surface labeling and mass spectrometry reveal diversity of cell surface markers and signaling molecules expressed in undifferentiated mouse embryonic stem cells. Mol. Cell. Proteomics 2005, 4, 1968-1976.
76. Fujiki, Y., Hubbard, A. L., Fowler, S., Lazarow, P. B., Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J. Cell Biol. 1982, 93, 97-102.
77. Ghosh, D., Beavis, R. C., Wilkins, J. A., The identification and characterization of membranome components. J. Proteome Res. 2008, 7, 1572-1583.
78. Chaney, L. K., Jacobson, B. S., Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. J. Biol. Chem. 1983, 258, 10062-10072.
79. Spector, D. L., Goldman, R. D., Leinwand, L. A., Plasma membrane isolation using the cationic colloidal silica isolation technique. Cells: A Laboratory Manual 1998, 1, 35.31-35.14.
80. Goode, R. J. A., Simpson, R. J., in: Pierce, M. J., Wait, R. (Eds.) Proteomic Analysis of Membrane Proteins: Methods and Protocols, Humana Press, 2009, pp 177-187.
81. Rahbar, A. M., Fenselau, C., Integration of Jacobson's pellicle method into proteomic strategies for plasma membrane proteins. J. Proteome Res. 2004, 3, 1267-1277.
82. Rahbar, A. M., Fenselau, C., Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells. J. Proteome Res. 2005, 4, 2148-2153.
83. Durr, E., Yu, J., Krasinska, K. M., Carver, L. A. et al., Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat. Biotechnol. 2004, 22, 985-992.
84. Baharvand, H., Fathi, A., van Hoof, D., Salekdeh, G. H., Concise review: Trends in stem cell proteomics. Stem Cells 2007, 25, 1888-1903.
85. Jeong, J. A., Ko, K. M., Park, H. S., Lee, J. et al., Membrane proteomic analysis of human mesenchymal stromal cells during adipogenesis. Proteomics 2007, 7, 4181-4191.
86. Foster, L. J., Zeemann, P. A., Li, C., Mann, M. et al., Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 2005, 23, 1367-1377.
87. Dormeyer, W., van Hoof, D., Braam, S. R., Heck, A. J. et al., Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J. Proteome Res. 2008, 7, 2936-2951.
88. Speers, A. E., Wu, C. C., Proteomics of integral membrane proteins-theory and application. Chem. Rev. 2007, 107, 3687-3714.
89. Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M. et al., Characterization of human embryonic stem cell lines by the international stem cell initiative. Nat. Biotechnol. 2007, 25, 803-816.
90. Andrews, P. W., Benvenisty, N., McKay, R., Pera, M. F. et al., The international stem cell initiative: Toward benchmarks for human embryonic stem cell research. Nat. Biotechnol. 2005, 23, 795-797.
91. Whetton, A. D., Williamson, A. J., Krijgsveld, J., Lee, B. H. et al., The time is right: Proteome biology of stem cells. Cell Stem Cell 2008, 2, 215-217.
92. Yu, J., Thomson, J. A., Regenerative Med. Department of Health and Human Services, August 2006, pp 1-12.
93. Sell, S., Pierce, G. B., Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 1994, 70, 6-22.
94. Simpson, R. J., Connolly, L. M., Eddes, J. S., Pereira, J. J. et al., Proteomic analysis of the human colon carcinoma cell line (LIM 1215): Development of a membrane protein database. Electrophoresis 2000, 21, 1707-1732.
95. Adam, P. J., Boyd, R., Tyson, K. L., Fletcher, G. C. et al., Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J. Biol. Chem. 2003, 278, 6482-6489.
96. Foster, L. J., de Hoog, C. L., Zhang, Y., Zhang, Y. et al., A mammalian organelle map by protein correlation profiling. Cell 2006, 125, 187-199.
97. Peirce, M. J., Wait, R., Begum, S., Saklatvala, J., Cope, A. P., Expression profiling of lymphocyte plasma membrane proteins. Mol. Cell. Proteomics 2004, 3, 56-65.
98. Zhao, Y., Zhang, W., Kho, Y., Zhao, Y., Proteomic analysis of integral plasma membrane proteins. Anal. Chem. 2004, 76, 1817-1823.
99. Zhao, Y., Zhang, W., White, M. A., Zhao, Y., Capillary high-performance liquid chromatography/mass spectrometric analysis of proteins from affinity-purified plasma membrane. Anal. Chem. 2003, 75, 3751-3757.
100. Zhang, W., Zhou, G., Zhao, Y., White, M. A., Zhao, Y., Affinity enrichment of plasma membrane for proteomics analysis. Electrophoresis 2003, 24, 2855-2863.
101. Harder, T., Kuhn, M., Immunoisolation of TCR signaling complexes from Jurkat T leukemic cells. Sci. STKE 2001, 2001, PL1.
102. Luers, G. H., Hartig, R., Mohr, H., Hausmann, M. et al., Immuno-isolation of highly purified peroxisomes using magnetic beads and continuous immunomagnetic sorting. Electrophoresis 1998, 19, 1205-1210.
103. Stan, R. V., Roberts, W. G., Predescu, D., Ihida, K. et al., Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae). Mol. Biol. Cell 1997, 8, 595-605.
104. Wubbolts, R., Leckie, R. S., Veenhuizen, P. T., Schwarzmann, G. et al., Proteomic and biochemical analyses of human B cell-derived exosomes: Potential implications for their function and multivesicular body formation. J. Biol. Chem. 2003, 278, 10963-10972.
105. Ghosh, D., Krokhin, O., Antonovici, M., Ens, W. et al., Lectin affinity as an approach to the proteomic analysis of membrane glycoproteins. J. Proteome Res. 2004, 3, 841-850.
106. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E. et al., Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63, 5821-5828.
107. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A. et al., Identification of human brain tumour initiating cells. Nature 2004, 432, 396-401.
108. O'Brien, C. A., Pollett, A., Gallinger, S., Dick, J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445, 106-110.
109. Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M. et al., Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445, 111-115.
110. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F. et al., Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67, 1030-1037.
111. Barker, N., van Es, J. H., Kuipers, J., Kujala, P. et al., Identification of stem cells in small intestine and colon bymarker gene Lgr5. Nature 2007, 449, 1003-1007.
112. Vermeulen, L., Todaro, M., de Sousa Mello, F., Sprick, M. R. et al., Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 2008, 105, 13427-13432.
113. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., Clarke, M. F., Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 3983-3988.
114. Eramo, A., Lotti, F., Sette, G., Pilozzi, E. et al., Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15, 504-514.
115. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A. et al., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1, 313-323.
116. Suetsugu, A., Nagaki, M., Aoki, H., Motohashi, T. et al., Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 2006, 351, 820-824.
117. Yin, S., Li, J., Hu, C., Chen, X. et al., CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 2007, 120, 1444-1450.
118. Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T. et al., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 2007, 104, 973-978.
119. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., Maitland, N. J., Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65, 10946-10951.
120. Mor, G., American Association of Cancer Research, San Diego, 2008, p. 2029.
121. Jordan, C. T., Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia 2002, 16, 559-562.
122. Dix, M. M., Simon, G. M., Cravalt, B. F., Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 2008, 134, 679-691.